Results 191 to 200 of about 340,102 (305)

Incidence of High-Risk Prostate Cancer in Korea: Insights From Real-World Data Between 2010 and 2020. [PDF]

J Korean Med Sci
Ko YH, Kim SW, Son NH.
europepmc   +1 more source

A Deep Learning Framework for Forecasting Medium‐Term Covariance in Multiasset Portfolios

Journal of Forecasting, EarlyView.
ABSTRACT Forecasting the covariance matrix of asset returns is central to portfolio construction, risk management, and asset pricing. However, most existing models struggle at medium‐term horizons, several weeks to months, where shifting market regimes and slower dynamics prevail.
Pedro Reis, Ana Paula Serra, João Gama
wiley   +1 more source

Prostate cancer presenting as brain metastasis with concurrent elevation of carcinoembryonic antigen and carbohydrate antigen 19-9 levels: illustrative case. [PDF]

J Neurosurg Case Lessons
Sumiyoshi S, Fujii K, Kasashima K, Oda M, Saiki M.   +4 more
europepmc   +1 more source

Embedded AI‐Enabled Wearable Piezoelectric Sensing Cluster for Real‐Time Multijoint Motion Recognition

Interdisciplinary Materials, EarlyView.
The distributed multijoint motion recognition cluster based on polyvinylidene fluoride membranes with high piezoelectric properties adopted a one‐master‐multiple‐slaves architecture and multipoint wireless collaboration to synchronously recognize motions of the wrist, elbow, and shoulder.
Zhongkun Wang, Jiagui Li, Puen Zhou, Yuanzheng Zhang, Yuhao Chen, Yonghui Wu, Yaju Zhang, Yong Qin, Haiwu Zheng   +8 more
wiley   +1 more source

European Society of Urogenital Radiology (ESUR) perspectives on the role of prostate MRI in active surveillance. [PDF]

Insights Imaging
Ursprung S, Gutierrez PA, Baroni RH, Nicola R, Salvador R, De Visschere P, Yakar D, Giganti F, Asbach P, the ESUR Prostate MRI Working Group.   +9 more
europepmc   +1 more source

Polygenic risk score and prostate specific antigen predict death from prostate cancer in men with intermediate aggressive cancer

International Journal of Cancer, EarlyView.
What's New? Using 21 SNPs, two novel PRS were constructed and used to develop two new machine‐learning classifiers, one for the detection of prostate cancer and the other for the prediction of its aggressiveness and subsequent mortality. The classifier for disease detection is built using the PRS as the sole feature, whereas the one for disease ...
Leandro Rodrigues Santiago, Efthymios Ladoukakis, Dorota Scibior‐Bentkowska, Belinda Nedjai   +3 more
wiley   +1 more source

The Role of Central Sensitization and Emotional Comorbidities in Temporomandibular Involvement Among Patients with Psoriatic Arthritis. [PDF]

Life (Basel)
Blanco JA, Márquez A, Toledano E, Queiro R, Martín-Vallejo J, Fernández-Gómez MJ, Chacón C, Díaz-Peña R, Martín D, Hidalgo C, Sánchez MD, León González M, Montilla C.   +12 more
europepmc   +1 more source

Comparing the effectiveness of prostate cancer screening protocols: European Association of Urology– and European Randomized Study of Screening for Prostate Cancer–based strategies

International Journal of Cancer, EarlyView.
What's New? Although screening reduces prostate cancer mortality, concerns about overdiagnosis and unnecessary biopsies have given rise to more tailored strategies. The European Association of Urology (EAU) proposed a risk‐adapted screening strategy combining prostate‐specific antigen (PSA)‐based intervals, a risk calculator, and magnetic resonance ...
Zhenwei Yang, Luuk A. van Duuren, Monique J. Roobol, Nicole S. Erler, Dimitris Rizopoulos, Eveline A. M. Heijnsdijk   +5 more
wiley   +1 more source

The Association Between SARS-CoV-2 Exposure, COVID-19 Vaccination and Psoriatic Arthritis-A Nested Case-Control Study. [PDF]

Vaccines (Basel)
Haddad A, Zabari Parnis E, Stein N, Gazitt T, Saliba W, Zisman D.   +5 more
europepmc   +1 more source

Evaluating the Impact of Age on Prostate Cancer Overdiagnosis Using Long‐Term Follow‐Up From the CAP Randomised Trial

International Journal of Cancer, EarlyView.
Uncertainty persists over whether the benefits of prostate‐specific antigen (PSA) screening outweigh harms from overdiagnosis, a key barrier to population‐wide adoption. Here, English male mortality rates were analyzed alongside long‐term data from the UK Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) to estimate age‐specific ...
Adam R. Brentnall, Matejka Rebolj, Peter Sasieni, Garth Funston, Rhian Gabe, Andrew J. Vickers   +5 more
wiley   +1 more source